Last reviewed · How we verify
Meningococcal B Vaccine NZ — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Meningococcal B Vaccine NZ (Meningococcal B Vaccine NZ) — Public Health England.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Meningococcal B Vaccine NZ TARGET | Meningococcal B Vaccine NZ | Public Health England | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Meningococcal B Vaccine NZ CI watch — RSS
- Meningococcal B Vaccine NZ CI watch — Atom
- Meningococcal B Vaccine NZ CI watch — JSON
- Meningococcal B Vaccine NZ alone — RSS
Cite this brief
Drug Landscape (2026). Meningococcal B Vaccine NZ — Competitive Intelligence Brief. https://druglandscape.com/ci/meningococcal-b-vaccine-nz. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab